Background: Atherosclerosis, with its major manifestation, coronary artery disease (CAD) is a chronic inflammatory disease. Dietary fatty acids intakes favorably effect on inflammatory responses. This study was conducted to examine the association between dietary fatty acid intakes and inflammatory markers, interleukin 6 (IL-6) and high sensitivity C-reactive protein (hs-CRP), in CAD patients among Iranian population.
INTRODUCTION
Inflammation plays an essential role in development of insulin resistance and type 2 diabetes, initiation and progression of atherosclerotic lesions, and plaque disruption. [1, 2] Interleukin-6 (IL-6), is an inflammatory cytokine and one of the main inducers of C-reactive protein (CRP) secretion in the liver. [3, 4] Atherosclerosis,
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with its major manifestation, coronary artery disease (CAD) is the major cause of morbidity and mortality in the world. [5] Reports have documented CAD incidence rates to be as high as 166 per 100,000 in Middle Eastern countries. [6] CAD is also the most important cause of morbidity and mortality in Iran and includes about 50% of all the deaths. [7] It is being recognized that traditional risk factors; such as dietary fats, smoking, dyslipidemia, hypertension, and diabetes; do not explain the presence of coronary atherosclerosis in a large proportion of patients. [8] During the past decade, with the recognition that atherosclerosis is an inflammatory process, several inflammatory markers have also been considered as a potential tool for prediction of coronary events and the observations taken together suggest that atherosclerosis is a chronic inflammatory disease. [9] The results of experimental and epidemiological studies have shown that habitual diet is the most important modifiable risk factor for prevention and control of CAD. [10] [11] [12] Dietary fat intake has long been implicated in the etiology of cardiovascular disease (CVD) and study of lipids and their major structural elements, the fatty acids, remains one of the most enigmatic research fields in nutrition and biology. [13] The results of experimental studies have shown that the quantity and quality of dietary fat intake influence on intensity and rate of inflammatory responses. [14] High intakes of trans fatty acids (TFAs) were associated with increased tumor necrosis factor (TNF) system activity not only among healthy women, [15] but also among patients with established heart disease. [16] A study in Iran revealed that healthy women with higher intakes of partially hydrogenated vegetable oils (PHVOs), a rich source of TFAs, had elevated concentrations of inflammatory biomarkers, whereas higher intakes of non-hydrogenated vegetable oils (non-HVOs) are associated with lower plasma concentrations of these biomarkers. [15] Polyunsaturated fatty acids (PUFA) including n-3 and n-6 fatty acids are substrates for human eicosanoids production. Eicosanoids derived from n-3 fatty acids have fewer inflammatory properties than those derived from n-6 fatty acids. [17] In Nurses' Health Study (NHS) and Health Professional Follow-up Study (HPFS), two prospective cohort studies, intakes of n-3 fatty acids were modestly inversely related to CRP levels. [18] n-6 PUFA consumption shows variable effects on inflammation, both anti-inflammatory and pro-inflammatory effects. [18, 19] Monounsaturated fatty acids (MUFAs) are predominant in olive oil, and have received increased attention as being potentially beneficial because of their association with low rates of coronary heart disease (CHD) in olive oil consuming populations of the Mediterranean basin. [20] Recommendations to decrease the intake of saturated fatty acids (SFAs) have been as a goal in prevention of CAD. In PIVUS study, a Swedish cross-sectional population based study of healthy elderly men and women, failed to identify a relationship between levels of SFAs in cholesteryl esters and high sensitivity-CRP (hs-CRP) concentration. [21] It is expected that CAD will be the leading cause of death in developing countries by the year 2020. [22] Limited data are available from Asian countries linking dietary fatty acids intake to plasma inflammatory markers, especially in patient with CAD. The present study was conducted to examine the relationship between dietary fatty acids and inflammatory markers, IL-6 and hs-CRP, in angiographically defined CAD among Iranian population.
MATERIALS AND METHODS

Participant population
The present hospital-based cross-sectional study was conducted in Chamran Heart Hospital, Isfahan, Iran in 2012. This study included 150 CAD male patients undergoing diagnostic coronary angiography at the Angiography Department of this hospital. Patients aged ≥45 years with first ever symptomatic CAD were included. The patients with prior history of CAD, any systemic inflammation, recent trauma, kidney disease, liver disease, cancer, and autoimmune disease were excluded from the study. We selected patients through consecutive sampling procedure. Participants were conscious and able to answer the questions. Written informed consent was obtained from each participant.
Angiographic estimation of CAD
The coronary angiogram is a two dimensional picture of inner lumen of the artery. Coronary angiography was performed by femoral approach and included at least four views of the left coronary artery and two views of right coronary artery. Each of eight vessel segments indicates the status of coronary stenosis. CAD was defined when a person had at least one epicardial vessel with more than 50% stenosis. The study protocol was approved by local Ethics Review Committee of Isfahan University of Medical Sciences.
Assessment of dietary intake
Usual dietary intake was assessed using a validated 168-item semi-quantitative food frequency questionnaire (FFQ). [23] A trained dietitian administered all the questionnaires. The FFQ consisted of a list of foods with standard serving sizes commonly consumed by Iranians. Participants were asked to report their frequency of consumption of a given serving of each food item during the previous year on a daily (e.g., bread), weekly (e.g., rice, meat), or monthly (e.g., fish) basis. The reported frequency for each food item was then converted to a daily intake. Portion sizes of consumed foods were converted to gram (g) using household measures. [24] Total energy intake was calculated by summing energy intakes from all item foods. N4 nutritional software was used to determine nutrient compositions of all foods. Total fat and total dietary fatty acids consumption was calculated by summing the consumption of fish (65-190 g/serving), tuna (75 g/serving), butter, margarine, hydrogenated vegetable oil, non-hydrogenated vegetable oil (olive oil, sunflower oil, soybean oil, corn oil, and canola oil), nuts (almond, walnut, hazelnut, pistachio, and peanut), animal oil, dairy fat, red meat fat, and mayonnaise. We also inquired about types of fats or oils used by each subject for frying, cooking, and baking.
Laboratory measurement
The 12-h fasting blood samples were collected into tubes containing 0.1% Ethylenediaminetetraacetic acid (EDTA) and were centrifuged at 4°C and 500 g for 10 min to separate plasma. Serum samples were promptly frozen (−20°C). Serum total cholesterol, low density lipoprotein (LDL), and triglyceride (TG) concentrations were measured by commercially available enzymatic reagents (Pars Azmoon, Iran) on a BT-3000 (Biotechnica) auto analyzer. High density lipoprotein (HDL) was also measured using a photometric enzyme assay (Pars Azmoon, Iran). Hs-CRP was measured by immunoturbidometry (Pars Azmoon, Iran) and IL-6 enzyme-linked immunosorbent assay (ELISA) was performed on serum (BBT International, England).
Assessment of other variables
Weight was measured using digital scales and recorded to the nearest 100 g, while the participants were minimally clothed without shoes. Height was measured in a standing position, without shoes, using a tape measure; while the shoulders were in a normal position. Body mass index (BMI) was calculated as weight in kg divided by height in m 2 . Waist circumference (WC) was measured at the narrowest level and that of the hip at maximum level over light clothing using an tape measure, without any pressure to body surface; measurements were recorded to the nearest 0.1 cm. Data on physical activity were obtained using participants' oral responses to an International Physical Activity Questionnaire and expressed as metabolic equivalent h/day (MET-h/day). [25] Additional covariate information regarding age, smoking status, medical history and current use of medications, and family history of diabetes mellitus and cardiovascular disease was obtained using questionnaires. Blood pressure was measured by an expert using a mercury sphygmomanometer and with the participant resting in a seated position for 10 min.
Statistical analysis
Statistical analyses were performed by using Statistical Package for Social Science (SPSS Inc, Chicago, IL, Version 18.0). General characteristics, biomarkers levels, and dietary intakes of participants across tertiles of total dietary fat intake were compared by the use of analysis of variance (ANOVA) and Chi-square where appropriate. Partial correlation analysis was performed to evaluate the association between fatty acid intakes and inflammatory markers. General linear model was used to examine the effect of fatty acid intakes including saturated fat, monounsaturated fat, linoleic acid (LA), a-linolenic acid (ALA), and eicosapentaenoic acid and docosahexaenoic acid (EPA + DHA) on plasma levels of inflammatory markers. We adjusted for age, waist circumference, BMI, physical activity, total energy intake, dietary cholesterol, protein, HDL, LDL, TG, serum total cholesterol, smoking status, hypertension, diabetes mellitus, family history of CVD, aspirin, and statins use. All probability values presented are two-tailed, and probability values below 0.05 were considered statistically significant. Values reported in the text are mean ± SD.
RESULTS
The energy-adjusted daily intakes (mean ± SD) of SFA, MUFA, linoleic acid, a-linolenic acid, and DHA + EPA were 27 ± 9, 22 ± 6, 21 ± 5, 0.48 ± 0.32, and 0.85 ± 0.82 g/d, respectively. General characteristics and laboratory features of study participants according to tertiles of total fat intake are presented in Tables 1 and 2 . Compared with patients in the lowest tertile, those in the upper teritle of fat intake had higher levels of IL-6 and lower levels of TG. Dietary intakes of study participants across tertiles of total fat intake are shown in Table 3 . Participants in the top tertile of fat intake had higher intakes of total energy, saturated fat, monounsaturated fat, linoleic acid, and cholesterol. Furthermore, CAD patients in the highest tertile of fat intake had lower intakes of carbohydrate and protein compared with those in the lowest tertile. No significant difference was found for other characteristics and dietary variables.
Partial correlation analysis was performed to evaluate association of fatty acid intakes with plasma IL-6 and hs-CRP concentrations. We adjusted for total energy, age, BMI, waist circumference, smoking status, hypertension, diabetes mellitus, family history of CVD,
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aspirin use, statin use, HDL, LDL, TG, serum total cholesterol, protein, dietary cholesterol, and physical activity. The correlation (r) between EPA + DHA and IL-6 was −0.25; P = 0.003 and hs-CRP was −0.38; P < 0.001. Monounsaturated fat was significantly inversely associated with plasma levels of IL-6 (r = −0.18; P = 0.03) and hs-CRP (r = −0.35; P < 0.001). SFA was directly related to IL-6 (r = 0.33; P = < 0.001) and hs-CRP (r = 0.22; P= < 0.001). The correlation of a-linolenic acid and IL-6 was −0.02; P = 0.81 and hs-CRP was −0.03; P = 0.69. No significant association was found for linoleic acid and IL-6 (r = −0.01; P = 0.91) and hs-CRP (r = −0.10; P = 0.22).
Multivariate-adjusted general linear model was used to examine effect of different fatty acids intakes on plasma inflammatory makers [ Table 4 ]. For two reasons, better fitting and no significane between BMI, age, protein, dietary cholesterol, aspirin and statin use with IL-6 and hs-CRP, these variables were not taken into account. The overall results of IL-6 changed slightly after use of this model. SFA was statistically significantly related to hs-CRP (P = 0.011) and IL-6 (P < 0.001) concentrations. MUFA and EPA + DHA were significantly related to plasma hs-CRP concentration, but not IL-6; albeit MUFA was modestly inversely related to IL-6 (P = 0.08). No significant relationships were observed for other fatty acids, a-linolenic acid, and linoleic acid.
DISCUSSION
In this cross-sectional study of dietary fatty acids and inflammatory markers, SFA was directly related to plasma IL-6 and hs-CRP levels. We observed statistically significant inverse association between n-3 fatty acids and MUFA intake with plasma levels of hs-CRP. The associations were restricted to long-chain PUFAs, EPA, and DHA and not ALA. In this study, we did not find statistically significant association between other fatty acids and inflammatory markers. To our knowledge, this study is the first to report association between dietary fat intake and inflammatory markers in patients with CAD from an Iranian population. Data are adjusted for energy intake, waist circumference, smoking status, hypertension, diabetes mellitus, family history of cardiovascular disease, high density lipoprotein, low density lipoprotein, triglyceride, serum total cholesterol, and physical activity. EPA and DHA: Eicosapentaenoic acid and docosahexaenoic acid CAD has been among the leading causes of death in Asian countries. [6] Inflammation plays a central role in development of atherosclerosis, and elevated CRP levels are an important risk factor for cardiovascular disease. [26] Similarly, plasma levels of IL-6 are also predictive of CVD; however, this relationship is less strong than for CRP, which may be due in part to higher variability or lower specificity of this cytokine. [27] Several studies have investigated the effects of different fatty acids on cytokines secretion, with conflicting results. A recent multicenter clinical trial performed on end-stage renal disease patients undergoing dialysis in Iran revealed that after supplementation with n-3 fatty acids, there was no statistically significant difference in the levels of hs-CRP (P = 0.44). [28] The ATTICA study in Greece found that total plasma n-6 fatty acids were inversely associated with hs-CRP and IL-6. [17] For Japanese men, but not women, there is an inverse relationship between dietary intake of both n-3 and n-6 PUFA and hs-CRP. [29] In a randomized crossover study, IL-6 concentrations were lower after consumption of oleic acid than after consumption of the SFAs; [30] however, no effects on CRP and IL-6 were observed in another randomized crossover study. [31] In LIPGENE study, a European multicenter dietary intervention study in subjects with metabolic syndrome, comparing high fat diets (MUFA or SFA) vs low fat diets, did not significantly alter the concentrations of CRP. [32] In contrast, a study of Indian adolescents and young adults found that for every 1% decrease in energy intake from SFAs, hs-CRP was decreased by 0.14 mg/L. [33] According to experimental studies [34, 35] and clinical trials [36] strong association has been described between cardiovascular disease and SFAs. Varied mechanisms have been proposed to account for pro-inflammatory effect of dietary SFA. Mechanisms responsible for these unhealthy effects of SFAs include: (1) Accumulation of diacylglycerol and ceramide; (2) activation of nuclear factor-KB and subsequent induction of inflammatory genes in white adipose tissue, immune cells, and myotubes; (3) decreased peroxisome proliferator-activated receptor gamma (PPAR-g) activation and adiponectin production, which decreases the oxidation of glucose and fatty acids; and (4) recruitment of immune cells like macrophages, neutrophils, and bone marrow-derived dendritic cells to white adipose tissue and muscle. [22] Our results are in agreement with known inflammatory action of SFA. A few studies suggest that dietary consumption of MUFA, oleic acid in particular, may have anti-inflammatory effects. [37, 38] In our study we found a statistically inverse association between MUFA with hs-CRP. Inconsistent findings in different studies might be dose related and might also be explained by lack of control for confounding variables in some studies and subject baseline levels of inflammatory markers. Fish and n-3 fatty acid intakes have received considerable attention in the recent past as potential dietary factors to reduce the risk of developing CAD. [39, 40] The association between n-3 fatty acids and reduced CVD risk has been attributed to a number of potential mechanisms, including effects on platelet function, plasma TG concentrations, inflammatory factors, and arrhythmia. [41, 42] In the current study, we failed to find a significant association between ALA intake and inflammatory markers. This might be attributed to more effective role of EPA and DHA in altering membrane composition and eicosanoid production. It was recently estimated that in humans, only 0.2% of plasma ALA is converted to EPA. [43, 44] The conversion rate of LA to arachidonic acid is also very low [45] ; however, because of the much higher intake, we speculate that LA still affects arachidonic acid concentrations; whereas ALA, because of its low intake and low conversion rate, has no substantial effect on EPA levels, and thus on inflammation. n-6 PUFA has long been considered as pro-inflammatory molecules because they are the main precursors of eicosanoids. [46] It is also argued that higher dietary intake of n-6 PUFA may lead to a competition between n-6 and n-3 metabolism resulting in a reduced production of anti-inflammatory molecules from n-3 PUFA. [47] However, in human subjects, higher intakes of n-6 fatty acids do not appear to be associated with elevated levels of inflammatory markers and there are no data from human studies that support a detrimental effect of dietary n-6 fatty acids on coronary heart disease. [48, 49] The present results are in contrast to customary assumption that high intake of n-6 fatty acids antagonizes the anti-inflammatory effects of n-3 fatty acids. One possible explanation for our observation is that the activities of n-6 fatty acids D6 and D5-desaturase (which are the rate-limiting steps for arachidonic acid and EPA synthesis in humans) and the activity of cyclooxygenase are inhibited by both n-3 and n-6 PUFAs. Through this mechanism, high intake of both types of fatty acids could reduce inflammatory mediators. [50, 51] Our study has several limitations. In this study we used N4 nutritional software to determine nutrient compositions of all food items, but this software did not have any information about trans-fatty acids. Our study has been done in the framework of cross-sectional study and there is no control group in this study. Also, the sample size of 150 individuals might be insufficient to detect possible associations between dietary fatty acids and inflammatory markers. Furthermore, cross-sectional design of the study would not allow | 2014 us to infer causality. Future longitudinal studies are required to further explore for the possible association. The next limitation is the use of FFQ as the dietary assessment method. The use of FFQ would result in misclassification of participants and this is usual with all nutritional epidemiologic studies. Although we controlled the analysis for several confounding variables, the existence of residual confounding cannot be excluded. Furthermore, random errors as in all epidemiologic studies might affect our results because diet and lifestyle information might be collected with some degree of errors. The existence of recall bias and selection bias in cross-sectional studies must also be taken into account. In the current study, it is possible that CAD patients might associate their disease to fat intake and therefore over-report consumption of fatty foods and oils. This is particularly relevant for our study because we enrolled newly diagnosed cases of CAD and as shown previously, [52] the interviewing close to the time of diagnosis may increase the potential for recall bias. However, some studies in the field of nutritional epidemiology that have assessed the effect of recall bias on the overall study results reported that this bias was minor and negligible. [53] Since all study participants were recruited from the province of Isfahan, Iran; the observed associations between dietary fatty acid and inflammatory markers may not generalize to other geographic areas.
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CONCLUSION
Given the above mentioned limitations, we found an inverse relationship between n-3 fatty acids, EPA and DHA, and MUFA with hs-CRP concentration in CAD patients. Our finding suggests that SFA was directly related to plasma IL-6 and hs-CRP levels. Further experimental and interventional studies under different conditions are needed to further explore for these associations.
